Jared Churko, PhD

Associate Professor, Cellular and Molecular Medicine
Director, iPS Cell Core
Assistant Professor, BIO5 Institute
Assistant Professor, Biomedical Engineering
Assistant Professor, Genetics GIDP
Assistant Professor, Physiological Sciences GIDP

Jared Churko, PhD, joined the University of Arizona Department of Cellular and Molecular Medicine in April 2018 following his position as an Instructor within Stanford University's Cardiovascular Institute. His lab is located within the Sarver Heart Center, where he studies heart development and cardiovascular disease. Specifically, his lab combines systems biology, stem cell biology, cardiac biology, genetic engineering, and bioinformatics to understand the mechanisms leading to heart disease. He is appointed as the Director of the University of Arizona iPSC Core funded by BIO5 and the UA Center for Innovation in Brain Science.

Molecular Medicine Grad Program: 
Yes

Bibliography

2022

Chakrabarti, J., R. Pandey, J. M. Churko, J. Eschbacher, S. Mallick, Y. Chen, B. Hermes, P. Mallick, B. N. Stansfield, K. W. Pond, et al., "Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing's Disease.", Cells, vol. 11, issue 21, 2022 Oct 23. PMCID: PMC9659185  PMID: 36359740

2021

Iwanski, J., S. G. Kazmouz, S. Li, B. Stansfield, T. T. Salem, S. Perez-Miller, T. Kazui, L. Jena, J. L. Uhrlaub, S. Lick, et al., "Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells.", Stem Cell Reports, 2021 Sep 01. PMCID: PMC8407952  PMID: 34525378
Salem, T., Z. Frankman, and J. Churko, "Tissue engineering techniques for iPSC derived three-dimensional cardiac constructs.", Tissue Eng Part B Rev, 2021 Sep 03. PMID: 34476988
Pivniouk, V., O. Pivniouk, A. DeVries, J. L. Uhrlaub, A. Michael, D. Pivniouk, S. R. VanLinden, M. Y. Conway, S. Hahn, S. P. Malone, et al., "The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.", J Allergy Clin Immunol, 2021 Dec 10. PMCID: PMC8660661  PMID: 34902435